The expansion, resulting from continued success and a year of growth across its key strategic partnerships, including top five pharmaceutical companies.
The partnership will see Quanticate support research into optimizing clinical trial design for rare disease and the role of response-adaptive randomisation. STOR-i was established in 2010 as an Engineering and Physical Sciences Resaearch Council EPSRC Cen